DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.
The increasing incidence of invasive fungal infections (IFI) in immunocompromised patients emphasizes the need to improve diagnostic tools. We established a DNA microarray to detect and identify DNA from 14 fungal pathogens (Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, Candida albicans, Candida dubliniensis, Candida glabrata, Candida lusitaniae, Candida tropicalis, Fusarium oxysporum, Fusarium solani, Mucor racemosus, Rhizopus microsporus, Scedosporium prolificans, and Trichosporon asahii) in blood, bronchoalveolar lavage, and tissue samples from high-risk patients. The assay combines multiplex PCR and consecutive DNA microarray hybridization. PCR primers and capture probes were derived from unique sequences of the 18S, 5.8S, and internal transcribed spacer 1 regions of the fungal rRNA genes. Hybridization with genomic DNA of fungal species resulted in species-specific hybridization patterns. By testing clinical samples from 46 neutropenic patients with proven, probable, or possible IFI or without IFI, we detected A. flavus, A. fumigatus, C. albicans, C. dubliniensis, C. glabrata, F. oxysporum, F. solani, R. microsporus, S. prolificans, and T. asahii. For 22 of 22 patients (5 without IFI and 17 with possible IFI), negative diagnostic results corresponded with negative microarray data. For 11 patients with proven (n = 4), probable (n = 2), and possible IFI (n = 5), data for results positive by microarray were validated by other diagnostic findings. For 11 of 11 patients with possible IFI, the microarray results provided additional information. For two patients with proven and probable invasive aspergillosis, respectively, microarray results were negative. The assay detected genomic DNA from 14 fungal pathogens from the clinical samples, pointing to a high significance for improving the diagnosis of IFI.
Spiess
Birgit
B
III Medizinische Universitätsklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany.
Seifarth
Wolfgang
W
Hummel
Margit
M
Frank
Oliver
O
Fabarius
Alice
A
Zheng
Chun
C
Mörz
Handan
H
Hehlmann
Rüdiger
R
Buchheidt
Dieter
D
D001483:Base Sequence; D021903:DNA, Ribosomal Spacer / Q000235:genetics; D005658:Fungi / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D008969:Molecular Sequence Data; D009503:Neutropenia / Q000382:microbiology*; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D016133:Polymerase Chain Reaction
D021903:DNA, Ribosomal Spacer
J Clin Microbiol. 2003 May;41(5):1811-8
12734210
Clin Infect Dis. 2002 Jan 1;34(1):7-14
11731939
Clin Infect Dis. 2004 Feb 1;38(3):311-20
14727199
Leuk Lymphoma. 2004 Mar;45(3):463-8
15160907
J Clin Microbiol. 2004 Aug;42(8):3696-706
15297519
J Clin Microbiol. 2004 Sep;42(9):4016-24
15364984
J Clin Microbiol. 2004 Sep;42(9):4154-7
15365004
J Clin Microbiol. 2004 Oct;42(10):4419-31
15472288
Clin Infect Dis. 1994 Apr;18(4):525-32
8038305
J Clin Microbiol. 1997 Jun;35(6):1353-60
9163443
Curr Opin Infect Dis. 2005 Aug;18(4):314-9
15985827
J Clin Microbiol. 2005 Aug;43(8):3760-8
16081907
Med Mycol. 2005 May;43 Suppl 1:S139-45
16110806
J Clin Microbiol. 2005 Oct;43(10):4943-53
16207946
Haematologica. 2005 Nov;90 Suppl:ECR22
16266913
Br J Haematol. 2006 Jan;132(2):138-54
16398648
Int J Antimicrob Agents. 2006 Jun;27 Suppl 1:3-6
16707250
Pediatr Infect Dis J. 2006 Jul;25(7):634-9
16804435
J Med Microbiol. 2006 Sep;55(Pt 9):1197-209
16914649
J Clin Microbiol. 2006 Sep;44(9):3299-305
16954264
J Clin Microbiol. 2007 Feb;45(2):380-5
17122000
J Clin Microbiol. 2007 Mar;45(3):906-14
17251398
J Clin Microbiol. 1999 Dec;37(12):3865-71
10565898
J Clin Microbiol. 2000 Feb;38(2):586-90
10655350
J Clin Microbiol. 2000 Apr;38(4):1510-5
10747135
J Clin Microbiol. 2000 Nov;38(11):4186-92
11060088
Syst Appl Microbiol. 2000 Dec;23(4):563-72
11249027
Br J Haematol. 2001 Jul;114(1):93-8
11472350
J Virol Methods. 2003 Sep;112(1-2):79-91
12951215